Test Bank For Pharmacology Clear and Simple:
A Guide to Drug Classifications and Dosage Calculations,
4th Edition by Cynthia J. Watkins
Chapters 1 - 21
,
,Chapter5v 1.5v History5v of5v Pharmacology
Pharmacology5vClear5vand5vSimple-
5vA5vGuide5vto5vDrug5vClassifications5vand5vDosage5vCalculations5v4th5vEdition5vWatkins5vTest5vBank
1.
A5v nurse5v working5v in5v radiology5v administers5v iodine5v to5v a5v patient5v who5v is5v having
5v a5vcomputed5t v omography5v (CT)5v scan.5v The5v nurse5v working5v on5v the5v oncology5v unit5v
administers5vchemotherapy5v to5v patients5v who5v have5v cancer.5v At5v the5v Public5v Health5
vDepartment,5 v a5 v nurse5vadministers5v a5 v measles-mumps-
rubella5 v (MMR)5 v vaccine5vto5va5v 14-month-
old5vchild5v as5va5vroutine5v immunization.5v Which5vbranch5v of5vpharmacology5vbest5vdescr
ibes5vthe5vactions5vof5vall5vthree5vnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology5vis5v the5v study5v of5v the5v biologic5v effects5v of5v chemicals.5v Nurses5v are5vin
volved5vwith5v clinical5v pharmacology5v or5v pharmacotherapeutics,5v which5v is5v a5vbranch
5v of5vpharmacology5v that5v deals5v with5v the5v uses5v of5v drugs5v to5v treat,5v prevent,5vand5v di
agnose5v disease.5Tv he5v radiology5v nurse5v is5v administering5v a5v drug5v to5v help5vdiagnose5v
a5v disease.5v The5v oncology5vnurse5v is5v administering5v a5v drug5v to5v help5v treat5va5v diseas
e.5v Pharmacoeconomics5v includes5v any5vcosts5v involved5 v in5v drug5v therapy.5vPharmaco
dynamics5vinvolves5vhow5va5vdrug5vaffects5vthe5vbody5vand5vpharmacokinetics5vis5vhow5vt
he5vbody5vacts5von5vthe5vbody.
2.
A5vphysician5v has5vordered5v intramuscular5v (IM)5v injections5v of5v morphine,
5v a5vnarcotic,5v every5v45v hours5v as5v needed5v for5v pain5v in5va5v motor5v vehicle5v a
ccident5vvictim.5v The5v nurse5v is5vaware5v this5v drug5v has5v a5v high5v abuse5v pot
ential.5v Under5v what5cv ategory5vwould5vmorphine5vbe5vclassified?
A) Schedule5v I
B) Schedule5vII
C) Schedule5v III
D) Schedule5vIV
ANSWER: B
, Feedback:
Narcotics5vwith5va5vhigh5v abuse5v potential5vare5vclassified5vas5vSchedule5vII5vdr
ugs5vbecause5vof5v severe5v dependence5vliability.5v Schedule5v I5vdrugs5vhave5v hi
gh5v abuse5vpotential5v and5 v no5v accepted5v medical5v use.5v Schedule5v III5v drugs5
v have5v a5v lesser5vabuse5v potential5v than5v II5v and5v an5v accepted5v medical5v use.
5v Schedule5v IV5v drugs5v have5lvow5vabuse5v potential5vand5vlimited5v dependence5v
liability.
3.
When5v involved5v in5v phase5v III5v drug5v evaluation5v studies,5v what5 v respo
nsibilities5w
v ould5vthe5vnurse5vhave?
A) Working5v with5v animals5v who5v are5v given5v experimental5v drugs
B) Choosing5v appropriate5v patients5v to5v be5v involved5v in5v the5v drug5v study
C) Monitoring5v and5v observing5v patients5v closely5v for5v adverse5v effects
D) Conducting5v research5 v to5v determine5v effectiveness5v of5v the5 v drug
ANSWER: C
Feedback:
Phase5v III5vstudies5v involve5v use5v of5v a5v drug5vin5v a5v vast5v clinical5v population5v
in5v which5pv atients5v are5v asked5v to5v record5v any5v symptoms5v they5v experience5
v while5v taking5v the5vdrugs.5v Nurses5v may5vbe5v responsible5v for5v helping5v collect
5v and5v analyze5v the5vinformation5v to5v be5v shared5v with5v the5v Food5v and5v Drug5
v Administration5v (FDA)5v but5w v ould5v not5v conduct5v research5v independently5v
because5v nurses5v do5v not5v prescribe5vmedications.5v Use5v of5v animals5v in5v dru
g5v testing5v is5v done5v in5v the5v preclinical5v trials.5vSelect5v patients5v who5vare5v in
volved5v in5v phase5v II5v studies5v to5v participate5v in5v studies5vwhere5v the5v partici
pants5v have5v the5v disease5v the5v drug5v is5v intended5v to5v treat.5v These5vpatients
5v are5v monitored5v closely5v for5v drug5v action5v and5v adverse5v effects.5v Phase5v I5v
studies5v involve5v healthy5v human5v volunteers5v who5v are5v usually5vpaid5v for5v t
heir5vparticipation.5v Nurses5vmay5vobserve5v for5v adverse5veffects5v and5vtoxicit
y.
4.
What5v concept5v is5v considered5v when5v generic5v drugs5v are5v substituted
5v for5v brand5n
v ame5vdrugs?
A) Bioavailability
B) Critical5 v concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback:
A Guide to Drug Classifications and Dosage Calculations,
4th Edition by Cynthia J. Watkins
Chapters 1 - 21
,
,Chapter5v 1.5v History5v of5v Pharmacology
Pharmacology5vClear5vand5vSimple-
5vA5vGuide5vto5vDrug5vClassifications5vand5vDosage5vCalculations5v4th5vEdition5vWatkins5vTest5vBank
1.
A5v nurse5v working5v in5v radiology5v administers5v iodine5v to5v a5v patient5v who5v is5v having
5v a5vcomputed5t v omography5v (CT)5v scan.5v The5v nurse5v working5v on5v the5v oncology5v unit5v
administers5vchemotherapy5v to5v patients5v who5v have5v cancer.5v At5v the5v Public5v Health5
vDepartment,5 v a5 v nurse5vadministers5v a5 v measles-mumps-
rubella5 v (MMR)5 v vaccine5vto5va5v 14-month-
old5vchild5v as5va5vroutine5v immunization.5v Which5vbranch5v of5vpharmacology5vbest5vdescr
ibes5vthe5vactions5vof5vall5vthree5vnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology5vis5v the5v study5v of5v the5v biologic5v effects5v of5v chemicals.5v Nurses5v are5vin
volved5vwith5v clinical5v pharmacology5v or5v pharmacotherapeutics,5v which5v is5v a5vbranch
5v of5vpharmacology5v that5v deals5v with5v the5v uses5v of5v drugs5v to5v treat,5v prevent,5vand5v di
agnose5v disease.5Tv he5v radiology5v nurse5v is5v administering5v a5v drug5v to5v help5vdiagnose5v
a5v disease.5v The5v oncology5vnurse5v is5v administering5v a5v drug5v to5v help5v treat5va5v diseas
e.5v Pharmacoeconomics5v includes5v any5vcosts5v involved5 v in5v drug5v therapy.5vPharmaco
dynamics5vinvolves5vhow5va5vdrug5vaffects5vthe5vbody5vand5vpharmacokinetics5vis5vhow5vt
he5vbody5vacts5von5vthe5vbody.
2.
A5vphysician5v has5vordered5v intramuscular5v (IM)5v injections5v of5v morphine,
5v a5vnarcotic,5v every5v45v hours5v as5v needed5v for5v pain5v in5va5v motor5v vehicle5v a
ccident5vvictim.5v The5v nurse5v is5vaware5v this5v drug5v has5v a5v high5v abuse5v pot
ential.5v Under5v what5cv ategory5vwould5vmorphine5vbe5vclassified?
A) Schedule5v I
B) Schedule5vII
C) Schedule5v III
D) Schedule5vIV
ANSWER: B
, Feedback:
Narcotics5vwith5va5vhigh5v abuse5v potential5vare5vclassified5vas5vSchedule5vII5vdr
ugs5vbecause5vof5v severe5v dependence5vliability.5v Schedule5v I5vdrugs5vhave5v hi
gh5v abuse5vpotential5v and5 v no5v accepted5v medical5v use.5v Schedule5v III5v drugs5
v have5v a5v lesser5vabuse5v potential5v than5v II5v and5v an5v accepted5v medical5v use.
5v Schedule5v IV5v drugs5v have5lvow5vabuse5v potential5vand5vlimited5v dependence5v
liability.
3.
When5v involved5v in5v phase5v III5v drug5v evaluation5v studies,5v what5 v respo
nsibilities5w
v ould5vthe5vnurse5vhave?
A) Working5v with5v animals5v who5v are5v given5v experimental5v drugs
B) Choosing5v appropriate5v patients5v to5v be5v involved5v in5v the5v drug5v study
C) Monitoring5v and5v observing5v patients5v closely5v for5v adverse5v effects
D) Conducting5v research5 v to5v determine5v effectiveness5v of5v the5 v drug
ANSWER: C
Feedback:
Phase5v III5vstudies5v involve5v use5v of5v a5v drug5vin5v a5v vast5v clinical5v population5v
in5v which5pv atients5v are5v asked5v to5v record5v any5v symptoms5v they5v experience5
v while5v taking5v the5vdrugs.5v Nurses5v may5vbe5v responsible5v for5v helping5v collect
5v and5v analyze5v the5vinformation5v to5v be5v shared5v with5v the5v Food5v and5v Drug5
v Administration5v (FDA)5v but5w v ould5v not5v conduct5v research5v independently5v
because5v nurses5v do5v not5v prescribe5vmedications.5v Use5v of5v animals5v in5v dru
g5v testing5v is5v done5v in5v the5v preclinical5v trials.5vSelect5v patients5v who5vare5v in
volved5v in5v phase5v II5v studies5v to5v participate5v in5v studies5vwhere5v the5v partici
pants5v have5v the5v disease5v the5v drug5v is5v intended5v to5v treat.5v These5vpatients
5v are5v monitored5v closely5v for5v drug5v action5v and5v adverse5v effects.5v Phase5v I5v
studies5v involve5v healthy5v human5v volunteers5v who5v are5v usually5vpaid5v for5v t
heir5vparticipation.5v Nurses5vmay5vobserve5v for5v adverse5veffects5v and5vtoxicit
y.
4.
What5v concept5v is5v considered5v when5v generic5v drugs5v are5v substituted
5v for5v brand5n
v ame5vdrugs?
A) Bioavailability
B) Critical5 v concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback:
